Michael Lim

Michael KimMichael Lim, M.D., is director of the Brain Tumor Immunotherapy Program and a professor of neurosurgery, oncology, otolaryngology, and radiation oncology at Johns Hopkins. Lim’s research laboratory is focused on understanding the mechanisms of immune evasion by primary brain tumors. Lim obtained his M.D. from the Johns Hopkins University School of Medicine and completed his residency in neurosurgery at Stanford University Hospital. In addition to running a laboratory, he also directs the immunotherapy clinical trials program at Johns Hopkins. He currently serves as the principal investigator of several large brain tumor immunotherapy clinical trials based on findings from his laboratory.